TABLE 2.
Characteristics of 30 solid organ transplant recipients
| Transplant characteristics | Total SOT recipients (N = 30) |
|---|---|
| Type of SOT, no. (%) | |
| Kidney | 26 (87%) |
| Liver | 3 (10%) |
| Heart | 1 (3%) |
| Time from transplantation to COVID‐19 diagnosis in years—median (range) | 4.2 (0.1‐24.3) |
| Maintenance Immunosuppression—no. (%) | |
| Prednisone < 5 mg daily | 25 (83%) |
| Tacrolimus | 21 (70%) |
| Mycophenolate mofetil (MMF) | 19 (63%) |
| Belatacept | 6 (20%) |
| Azathioprine | 2 (7%) |
| Cyclosporine | 1 (3%) |
| Change to Immunosuppression on admission—no. (%) | |
| Discontinued MMF among SOT on MMF | 17 (89%) |
| Continued immunosuppression | 14 (45%) |